Gilead Sciences (GILD) Tops Q3 EPS by 51c; raises guidance
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $138.92 --0%
Financial Fact:
Income from operations: 4.4B
Today's EPS Names:
SYRS, EGRX, AIFC, More
Financial Fact:
Income from operations: 4.4B
Today's EPS Names:
SYRS, EGRX, AIFC, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q3 EPS of $2.02, $0.51 better than the analyst estimate of $1.51. Revenue for the quarter came in at $7.54 billion versus the consensus estimate of $7.01 billion.
GUIDANCE:
Gilead Sciences sees FY2024 EPS of $4.25-$4.45, versus the consensus of $3.81.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VNET Group (VNET) Misses Q2 EPS by 164c
- Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
- uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
